Cascara and Pantoprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cascara (cascara) and Pantoprazole (pantoprazole sodium). Common drug interactions include drug ineffective among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Cascara and Pantoprazole. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Cascara?

Cascara has active ingredients of cascara. eHealthMe is studying from 302 Cascara users. Check the latest studies of Cascara.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

On Jul, 20, 2026

31 people who take Cascara and Pantoprazole together, and have interactions are studied.

Cascara and Pantoprazole drug interactions.

What are the common drug interactions of Cascara and Pantoprazole, by gender? *:

female:

Drug ineffective
Dyspnoea (difficult or laboured respiration)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Lower respiratory tract infection
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nausea (feeling of having an urge to vomit)
Oedema peripheral (superficial swelling)
Pneumonia viral
Presyncope
Productive cough

male:

Constipation
Intestinal obstruction
Vomiting
Drug effect decreased
Post procedural complication
Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Cascara and Pantoprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Myoclonic epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs)

50-59:

Alopecia (absence of hair from areas of the body)
Depression
Dysstasia (difficulty in standing)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Drug effect decreased
Post procedural complication
Pulmonary embolism (blockage of the main artery of the lung)

60+:

Vomiting
Pulmonary embolism (blockage of the main artery of the lung)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nausea (feeling of having an urge to vomit)
Oedema peripheral (superficial swelling)
Pneumonia viral
Presyncope
Productive cough
Pyrexia (fever)
Upper respiratory tract infection

What are the existing conditions these people have? *

Asthma: 6 people, 19.35%
Depression: 3 people, 9.68%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 6.45%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 6.45%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 6.45%
Bone Pain: 2 people, 6.45%
Constipation: 2 people, 6.45%
Dry Eyes (lack of adequate tears): 2 people, 6.45%
Gait Disturbance: 2 people, 6.45%
Gastric Disorder (disease of stomach): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cascara and Pantoprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously